ALT250103C16000
- 0.00
- 0.000.00%
アルティミューンのニュース一覧
Institutional Owners May Consider Drastic Measures as Altimmune, Inc.'s (NASDAQ:ALT) Recent US$56m Drop Adds to Long-term Losses
Jim Cramer on Altimmune, Inc. (ALT): 'Healthcare Is So Out Of Fashion'
Most Shorted Stocks on Wall Street Heading Into 2025: BYND, KSS, GRPN, and More
We're Not Very Worried About Altimmune's (NASDAQ:ALT) Cash Burn Rate
Weight-loss Drugs in 2025, Auto Industry Outlook: Market Domination
Hims & Hers Shares Tumble as FDA Resolves Obesity Drug Shortage
Altimmune Added to Nasdaq Biotechnology Index
Merck-Hansoh Deal for Oral GLP-1 Hurts Obesity Drug Developers
Altimmune Shares Surge on CEO's CNBC Appearance
Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday
Altimmune Stock Up More Than 25% in a Month: Here's Why
Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders
安进(AMGN.US)发布减肥疗法MariTide中期数据 减重效果不输诺礼
Altimmune to Participate at Two Upcoming Investor Conferences
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
Executive Reshuffles: TWO, CYBR, PFG and ALT
Altimmune Presents New Data On The Effect Of Pemvidutide On Inflammatory Lipids In Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease At The Liver Meeting 2024
Altimmune Third Quarter 2024 Earnings: Beats Expectations
礼来惊吓，诺和诺德救场！减肥药市场前景依旧令众玩家垂涎
10 Health Care Stocks With Whale Alerts In Today's Session